Lifonebart is a humanized monoclonal antibody targeting TREM2 (triggering receptor expressed on myeloid cells 2). The antibody isotype of Lifonebart is human IgG1κ, and the recommended isotype control is Human IgG1 kappa, Isotype Control [1].
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
















